Physician profile
Ryan Cleary
NPI 1609210269
$3,792.41
in general payments reported to CMS, 2019-2025
22 companies · $690 in 2025
The $690 reported for 2025 was more than what 79% of Radiation Oncology providers received nationally (typical 2025 total: $172).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $142 · 2020: $2,292 · 2021: $75.71 · 2022: $350 · 2023: $125 · 2024: $117 · 2025: $690.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $833 · Education: $99.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $832.56 |
| Education | $99.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novocure INC. | $2,210.00 | 2019-2025 | Optune, Optune Gio, Optune Lua (Novottf-200t) |
| Boston Scientific Corporation | $222.06 | 2022-2025 | General - Male Sui |
| Astrazeneca Pharmaceuticals LP | $213.59 | 2019-2025 | |
| Siemens Medical Solutions USA, INC. | $141.14 | 2022-2023 | Somatom Go.Top |
| Galvanize Therapeutics, INC | $129.98 | 2025 | Aliya System |
| Monteris Medical Corporation | $121.87 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $109.42 | 2022-2025 | |
| Janssen Biotech, INC. | $99.99 | 2025 | Rybrevant |
| Glaxosmithkline, LLC. | $97.21 | 2020 | |
| Pfizer INC. | $91.86 | 2025 | |
| Tactile Systems Technology INC | $83.11 | 2021-2025 | Flexitouch Plus, Nimbl |
| Regeneron Healthcare Solutions, INC. | $59.26 | 2022-2023 | Libtayo |
| Angiodynamics, INC. | $38.87 | 2020-2021 | |
| Teleflex LLC | $31.46 | 2024 | |
| Accuray Incorporated | $22.50 | 2019 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $21.91 | 2019 | |
| Progenics Pharmaceuticals, INC. | $20.84 | 2024 | |
| Kyowa Kirin, INC. | $18.38 | 2025 | |
| Takeda Pharmaceuticals U.S.A., INC. | $16.93 | 2020 | |
| Novartis Pharmaceuticals Corporation | $16.85 | 2025 | |
| Brainlab, INC. | $13.67 | 2019 | |
| Blue Earth Diagnostics | $11.51 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ryan Cleary listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.